Company Filing History:
2 out of 170 
2 out of 1,743 
2 out of 269 
Years Active: 2021-2025
Title: Yujin Hoshida: Innovator in Hepatology
Introduction
Yujin Hoshida is a prominent inventor based in Englewood Cliffs, NJ (US). She has made significant contributions to the field of hepatology, particularly in the development of human cell culture models for liver diseases. With a total of 2 patents, her work focuses on advancing the understanding and treatment of liver conditions.
Latest Patents
Hoshida's latest patents include a groundbreaking invention titled "Clinical gene signature-based human cell culture model and uses thereof." This invention provides a robust human liver cell-based system that can induce a clinical Prognostic Liver Signature (PLS) high-risk gene signature through persistent hepatitis C infection, persistent hepatitis B infection, or ethanol exposure. The cellular model system is designed for the development and progression of hepatocellular carcinoma (HCC) and cirrhosis. It can be utilized in screening compounds that may be effective in treating or preventing cirrhosis and HCC, as well as in identifying biomarkers for predicting liver disease progression.
Career Highlights
Throughout her career, Hoshida has worked with esteemed institutions such as Université de Strasbourg and the Institut National de la Santé et de la Recherche Médicale. Her research has significantly impacted the understanding of liver diseases and has opened new avenues for therapeutic interventions.
Collaborations
Yujin Hoshida has collaborated with notable professionals in her field, including Thomas Baumert. These collaborations have further enriched her research and contributed to the advancement of hepatology.
Conclusion
Yujin Hoshida is a trailblazer in the field of liver disease research, with her innovative patents paving the way for new treatment options. Her contributions continue to influence the medical community and improve patient outcomes in hepatology.